Manufacturer record
Cortex Medical Inc: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Cortex Medical Inc (Himachal Pradesh) were declared Not of Standard Quality between May 2023 and October 2024. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: CMT23-1658, Telmisartan Tablets I.P. (Telesky-40 Tablet) (exp Feb 2026). RDTL Guwahati (CDSCO lab) found it not of standard quality: Dissolution. Listed in the October 2024 alert.
Records by type
2 records linked to Cortex Medical Inc in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Telmisartan Tablets I.P. (Telesky-40 Tablet) | Batch CMT23-1658Mfg Mar 2024 · Exp Feb 2026 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Oct 2024 |
| Nimesulide and Paracetamol Tablets (Nimfed Tablets) | Batch CMT22?666Mfg Sep 2022 · Exp Aug 2024 | Disintegration testDisintegration | RDTL ChandigarhState lab | May 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.